Capital Investment Advisors LLC Buys Shares of 1,298 DaVita Inc. (NYSE:DVA)

Capital Investment Advisors LLC purchased a new position in shares of DaVita Inc. (NYSE:DVA) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,298 shares of the company’s stock, valued at approximately $213,000.

Other hedge funds have also recently modified their holdings of the company. Blue Trust Inc. raised its position in shares of DaVita by 58.6% during the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. purchased a new stake in DaVita during the second quarter valued at approximately $43,000. Versant Capital Management Inc lifted its stake in shares of DaVita by 90.6% in the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock valued at $45,000 after purchasing an additional 155 shares during the last quarter. Friedenthal Financial purchased a new position in shares of DaVita in the 2nd quarter worth approximately $48,000. Finally, Point72 Hong Kong Ltd bought a new position in shares of DaVita during the 2nd quarter valued at approximately $68,000. Institutional investors own 90.12% of the company’s stock.

Insider Transactions at DaVita

In related news, CEO Javier Rodriguez sold 50,000 shares of the company’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $165.05, for a total value of $8,252,500.00. Following the completion of the sale, the chief executive officer now directly owns 837,835 shares of the company’s stock, valued at $138,284,666.75. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other DaVita news, COO Michael David Staffieri sold 9,539 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the completion of the sale, the chief operating officer now owns 241,945 shares in the company, valued at $36,299,008.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction on Monday, September 16th. The shares were sold at an average price of $165.05, for a total value of $8,252,500.00. Following the completion of the transaction, the chief executive officer now owns 837,835 shares in the company, valued at $138,284,666.75. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 173,482 shares of company stock valued at $27,387,069. 2.00% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on DVA shares. TD Cowen raised their price target on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. Bank of America lifted their price target on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th. UBS Group upped their price target on shares of DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Finally, Truist Financial raised their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $159.00.

DaVita Trading Down 0.3 %

Shares of DVA opened at $161.45 on Tuesday. The company has a debt-to-equity ratio of 9.94, a current ratio of 1.16 and a quick ratio of 1.12. The firm has a market capitalization of $14.16 billion, a price-to-earnings ratio of 18.35, a PEG ratio of 0.93 and a beta of 0.87. The company has a 50-day moving average of $156.74 and a 200 day moving average of $144.69. DaVita Inc. has a 1-year low of $75.47 and a 1-year high of $168.50.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.47 by $0.12. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.15 billion. During the same quarter in the previous year, the business earned $2.08 earnings per share. DaVita’s quarterly revenue was up 6.2% on a year-over-year basis. On average, research analysts expect that DaVita Inc. will post 9.99 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.